These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 20501634)
1. The effects of azole-based heme oxygenase inhibitors on rat cytochromes P450 2E1 and 3A1/2 and human cytochromes P450 3A4 and 2D6. Hum M; McLaughlin BE; Roman G; Vlahakis JZ; Szarek WA; Nakatsu K J Pharmacol Exp Ther; 2010 Sep; 334(3):981-7. PubMed ID: 20501634 [TBL] [Abstract][Full Text] [Related]
2. Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms. Kinobe RT; Vlahakis JZ; Vreman HJ; Stevenson DK; Brien JF; Szarek WA; Nakatsu K Br J Pharmacol; 2006 Feb; 147(3):307-15. PubMed ID: 16331285 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of heme oxygenase-1 partially reverses the arsenite-mediated decrease of CYP1A1, CYP1A2, CYP3A23, and CYP3A2 catalytic activity in isolated rat hepatocytes. Anwar-Mohamed A; Klotz LO; El-Kadi AO Drug Metab Dispos; 2012 Mar; 40(3):504-14. PubMed ID: 22159698 [TBL] [Abstract][Full Text] [Related]
4. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808 [TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions. Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129 [TBL] [Abstract][Full Text] [Related]
6. Proteolytic degradation of heme-modified hepatic cytochromes P450: A role for phosphorylation, ubiquitination, and the 26S proteasome? Korsmeyer KK; Davoll S; Figueiredo-Pereira ME; Correia MA Arch Biochem Biophys; 1999 May; 365(1):31-44. PubMed ID: 10222036 [TBL] [Abstract][Full Text] [Related]
7. In vitro effects of tacrolimus on human cytochrome P450. Lecointre K; Furlan V; Taburet AM Fundam Clin Pharmacol; 2002 Dec; 16(6):455-60. PubMed ID: 12685503 [TBL] [Abstract][Full Text] [Related]
8. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Duescher RJ; Elfarra AA Arch Biochem Biophys; 1994 Jun; 311(2):342-9. PubMed ID: 8203896 [TBL] [Abstract][Full Text] [Related]
9. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4. Spracklin DK; Thummel KE; Kharasch ED Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607 [TBL] [Abstract][Full Text] [Related]
10. Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat. Kobayashi K; Urashima K; Shimada N; Chiba K Drug Metab Dispos; 2003 Jul; 31(7):833-6. PubMed ID: 12814958 [TBL] [Abstract][Full Text] [Related]
11. Assessment of drug-drug interaction for silymarin. Doehmer J; Tewes B; Klein KU; Gritzko K; Muschick H; Mengs U Toxicol In Vitro; 2008 Apr; 22(3):610-7. PubMed ID: 18249085 [TBL] [Abstract][Full Text] [Related]
12. Gender differences in microsomal metabolic activation of hepatotoxic clivorine in rat. Lin G; Cui YY; Liu XQ Chem Res Toxicol; 2003 Jun; 16(6):768-74. PubMed ID: 12807360 [TBL] [Abstract][Full Text] [Related]
13. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib. Uttamsingh V; Lu C; Miwa G; Gan LS Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the enzymatic activity of heme oxygenases by azole-based antifungal drugs. Kinobe RT; Dercho RA; Vlahakis JZ; Brien JF; Szarek WA; Nakatsu K J Pharmacol Exp Ther; 2006 Oct; 319(1):277-84. PubMed ID: 16807364 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Appleton SD; Chretien ML; McLaughlin BE; Vreman HJ; Stevenson DK; Brien JF; Nakatsu K; Maurice DH; Marks GS Drug Metab Dispos; 1999 Oct; 27(10):1214-9. PubMed ID: 10497150 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of cytochrome P450 reactions by apo-cytochrome b5: evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5 or heme oxygenase. Yamazaki H; Shimada T; Martin MV; Guengerich FP J Biol Chem; 2001 Aug; 276(33):30885-91. PubMed ID: 11413149 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes. Reed JR; Cawley GF; Backes WL Drug Metab Lett; 2011 Jan; 5(1):6-16. PubMed ID: 20942796 [TBL] [Abstract][Full Text] [Related]
18. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1. Bu HZ; Magis L; Knuth K; Teitelbaum P Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532 [TBL] [Abstract][Full Text] [Related]
19. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes. Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639 [TBL] [Abstract][Full Text] [Related]
20. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes. Yeung JH; Or PM Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]